Cargando…

Recurrence Pattern of Cervical Cancer Based on the Platinum Sensitivity Concept: A Multi-Institutional Study from the FRANCOGYN Group

The standard of care for patients with advanced cervical cancer (ACC) includes platinum-based chemotherapy. The concept of platinum sensitivity is a major prognostic factor for patients with ovarian cancer. The aim of this study was to validate the applicability of the platinum sensitivity concept t...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Foucher, Tiphaine, Hennebert, Cecile, Dabi, Yohan, Ouldamer, Lobna, Lavoué, Vincent, Dion, Ludivine, Canlorbe, Geoffroy, Bolze, Pierre Adrien, Golfier, François, Akladios, Cherif, Lecointre, Lise, Kerbage, Yohan, Collinet, Pierre, Bricou, Alexandre, Carcopino, Xavier, Huchon, Cyrille, Raimond, Emilie, Graesslin, Olivier, Owen, Clémentine, Touboul, Cyril, Ballester, Marcos, Darai, Emile, Bendifallah, Sofiane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696862/ https://www.ncbi.nlm.nih.gov/pubmed/33198384 http://dx.doi.org/10.3390/jcm9113646

Ejemplares similares

Impact on Prognosis of the Surgical Route, Laparoscopy or Laparotomy, for the Surgical Staging of Early Stage Ovarian Cancer—A Study from the FRANCOGYN Group
por: Merlier, Margaux, et al.
Publicado: (2020)

Therapeutic value of surgical paraaortic staging in locally advanced cervical cancer: a multicenter cohort analysis from the FRANCOGYN study group
por: Dabi, Yohann, et al.
Publicado: (2018)

Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic - FRANCOGYN group for the CNGOF()
por: Akladios, Cherif, et al.
Publicado: (2020)

Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group
por: Rocher, Grégoire, et al.
Publicado: (2021)

Risk Factors for Recurrence of Borderline Ovarian Tumours after Conservative Surgery and Impact on Fertility: A Multicentre Study by the Francogyn Group
por: Ozenne, Adele, et al.
Publicado: (2022)

Ovarian Cancer in the Elderly: Time to Move towards a More Logical Approach to Improve Prognosis—A Study from the FRANCOGYN Group
por: Dion, Ludivine, et al.
Publicado: (2020)

Management and Survival of Elderly and Very Elderly Patients with Ovarian Cancer: An Age-Stratified Study of 1123 Women from the FRANCOGYN Group
por: Joueidi, Yolaine, et al.
Publicado: (2020)

Prise en charge chirurgicale des cancers gynécologiques en période de pandémie COVID-19 – Recommandations du Groupe FRANCOGYN pour le CNGOF
por: Akladios, C., et al.
Publicado: (2020)

Status of Surgical Management of Borderline Ovarian Tumors in France: are Recommendations Being Followed? Multicentric French Study by the FRANCOGYN Group
por: Lecointre, Lise, et al.
Publicado: (2021)

Using a new diagnostic tool to predict lymph node metastasis in advanced epithelial ovarian cancer leads to simple lymphadenectomy decision rules: A multicentre study from the FRANCOGYN group
por: Mimoun, Camille, et al.
Publicado: (2021)

Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group
por: Reboux, Pierre-Alain, et al.
Publicado: (2019)

Presentation and Prognosis of Primary Expansile and Infiltrative Mucinous Carcinomas of the Ovary
por: Huin, Marine, et al.
Publicado: (2022)

Identification of a low risk population for parametrial invasion in patients with early-stage cervical cancer
por: Dabi, Yohann, et al.
Publicado: (2018)

Predicting poor prognosis recurrence in women with endometrial cancer: a nomogram developed by the FRANCOGYN study group
por: Ouldamer, Lobna, et al.
Publicado: (2016)

Impact of Lymphadenectomy on Survival of Patients with Serous Advanced Ovarian Cancer After Neoadjuvant Chemotherapy: A French National Multicenter Study (FRANCOGYN)
por: Bund, Virginie, et al.
Publicado: (2020)

Patients with stage IV epithelial ovarian cancer: understanding the determinants of survival
por: Dabi, Yohann, et al.
Publicado: (2020)

The impact of the COVID-19 coronavirus pandemic on the surgical management of gynecological cancers: Analysis of the multicenter database of the French SCGP and the FRANCOGYN group
por: Jouen, Théo, et al.
Publicado: (2021)

A Suggested Modification to FIGO Stage IV Epithelial Ovarian Cancer
por: Métairie, Marie, et al.
Publicado: (2023)

Onco-gynecologic surgery in the COVID-19 era: Risks and precautions—A position paper from FRANCOGYN, SCGP, SFCO, and SFOG
por: Lavoué, Vincent, et al.
Publicado: (2020)

Just how accurate are the major risk stratification systems for early-stage endometrial cancer?
por: Bendifallah, S, et al.
Publicado: (2015)

Results of a 2021 French National Survey on Management of Patients with Advanced Stage Epithelial Ovarian Cancer
por: Drouin, Leonor, et al.
Publicado: (2021)

Impact of the first lockdown for coronavirus 19 on breast cancer management in France: A multicentre survey
por: Murris, Floriane, et al.
Publicado: (2021)

A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion
por: Bendifallah, S, et al.
Publicado: (2014)

Machine learning algorithms as new screening approach for patients with endometriosis
por: Bendifallah, Sofiane, et al.
Publicado: (2022)

Insight on Non-Coding RNAs from Biofluids in Ovarian Tumors
por: Dabi, Yohann, et al.
Publicado: (2023)

Assessment of Lymph Node Involvement with PET-CT in Advanced Epithelial Ovarian Cancer. A FRANCOGYN Group Study
por: Tardieu, Antoine, et al.
Publicado: (2021)

An external validation study of nomograms designed to predict isolated loco-regional and distant endometrial cancer recurrences: how applicable are they?
por: Bendifallah, S, et al.
Publicado: (2013)

Salivary MicroRNA Signature for Diagnosis of Endometriosis
por: Bendifallah, Sofiane, et al.
Publicado: (2022)

Endometriosis Associated-miRNome Analysis of Blood Samples: A Prospective Study
por: Bendifallah, Sofiane, et al.
Publicado: (2022)

The Use of microRNAs in the Management of Endometrial Cancer: A Meta-Analysis
por: Delangle, Romain, et al.
Publicado: (2019)

Role of miRNAs in Normal Endometrium and in Endometrial Disorders: Comprehensive Review
por: Kolanska, Kamila, et al.
Publicado: (2021)

Clues for Improving the Pathophysiology Knowledge for Endometriosis Using Serum Micro-RNA Expression
por: Dabi, Yohann, et al.
Publicado: (2022)

MicroRNome analysis generates a blood-based signature for endometriosis
por: Bendifallah, Sofiane, et al.
Publicado: (2022)

Overview of non-coding RNAs in breast cancers
por: Dabi, Yohann, et al.
Publicado: (2022)

A Bioinformatics Approach to MicroRNA-Sequencing Analysis Based on Human Saliva Samples of Patients with Endometriosis
por: Bendifallah, Sofiane, et al.
Publicado: (2022)

Multicenter External Validation of the Deep Pelvic Endometriosis Index Magnetic Resonance Imaging Score
por: Thomassin-Naggara, Isabelle, et al.
Publicado: (2023)

Value of non-coding RNAs to assess lymph node status in cervical cancer
por: Dabi, Yohann, et al.
Publicado: (2023)

Identification of micro-RNA expression profile related to recurrence in women with ESMO low-risk endometrial cancer
por: de Foucher, Tiphaine, et al.
Publicado: (2018)

Multi-Disciplinary Care Planning of Ovarian Cancer in Older Patients: General Statement—A Position Paper from SOFOG-GINECO-FRANCOGYN-SFPO
por: Bengrine, Leila, et al.
Publicado: (2022)

Associated Lichen Sclerosis Increases the Risk of Lymph Node Metastases of Vulvar Cancer
por: Dabi, Yohann, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f2klaf6ipmac0dc0smjv6dst2s